Drug news
FDA approve Contour Next EZ (Bayer HealthCare) for blood glucose monitoring
The FDA has cleared the Contour Next EZ blood glucose monitoring system, from Bayer HealthCare, for use by diabetic patients in the US. The Contour Next EZ includes an easy-to-use meter and test strip sensors with innovative technology for advanced accuracy. Bayer's new BGM system is being introduced on a market-by-market basis and is currently available in other countries as the Contour XT. In the US Contour Next EZ will be available this summer.